Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.D., Catholic University (Italy) 1986
• 

  Duke Appointment History

  • Associate Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Addiction, Psychiatry & Behavioral Sciences 2014 - 2019
  • Associate Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Addiction, Psychiatry & Behavioral Sciences 2006 - 2014
  • Associate Clinical Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Translational Neuroscience, Psychiatry & Behavioral Sciences 2005 - 2006
  • Associate Research Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Translational Neuroscience, Psychiatry & Behavioral Sciences 2005
  • Clinical Associate in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Translational Neuroscience, Psychiatry & Behavioral Sciences 2004 - 2005
• Research
• 

  Selected Grants

  • Impact of new standards for tobacco products among dual e-cigarette/combusted cigarette users awarded by National Institutes of Health 2019 - 2022
  • Early-phase Studies of a Tailored Evidence-Based Smoking Cessation mHealth App for Persons Living with HIV awarded by National Institutes of Health 2019 - 2021
  • Alkermes ALK6428-A302 2017 - 2020
  • Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers awarded by National Institutes of Health 2016 - 2020
  • Mid Southern Primary Care Networks Node awarded by National Institutes of Health 2015 - 2020
  • Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace awarded by University of Minnesota 2018 - 2020
  • Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Individuals awarded by National Institutes of Health 2013 - 2020
  • ALK648-A301 - NXT-VIV 2016 - 2019
  • Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers awarded by National Institutes of Health 2015 - 2019
  • A feasibility study for testing the effects of extended-release naltrexone (Vivitrol) on recidivism and other participant outcomes in drug court settings 2016 - 2019
  • RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse awarded by National Institutes of Health 2013 - 2019
  • Retrospective Evaluation of Zubsolv Outcomes - A Longitudinal View (REZOLV) 2015 - 2018
  • Carolinas Comprehensive Substance Abuse Services Project 2012 - 2018
  • Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace awarded by University of Minnesota 2017
  • Project 2: Evaluating New Nicotine Standards for Cigarettes - Supplement awarded by University of Minnesota 2014 - 2017
  • Southern Consortium Node of the Clinical Trials Network awarded by Medical University of South Carolina 2013 - 2015
  • Carolina Alcohol and Drug Expansion Team (CADET) 2007 - 2013
  • Epidemiology of Non-Medical Prescription Analgesic Use awarded by National Institutes of Health 2007 - 2012
  • Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Use/Abuse awarded by National Institutes of Health 2008 - 2011
  • Place of Low-Dose Naltrexone in Opiate Detoxification awarded by National Institutes of Health 2004 - 2006
  • Serotonin and Cocaine Dependence awarded by National Institutes of Health 2003 - 2006
• 

  Industry Relationships

  • Alkermes, Inc.
  • Global Guidepoint
  • Health Advances LLC
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Mannelli, Paolo, and Li-Tzy Wu. “Commentary on Winhusen et al. (2019): Substance use disorders, chronic diseases, and electronic health records-a paradigm for screening and intervention..” Addiction 114, no. 8 (August 2019): 1471–72. https://doi.org/10.1111/add.14659.
       Full Text  Open Access Copy  Link to Item
    • Mannelli, Paolo, and Li-Tzy Wu. “Clinical epidemiology of substance use disorders: Understanding patterns, sharing knowledge, planning interventions..” Indian J Med Res 149, no. 4 (April 2019): 443–45. https://doi.org/10.4103/ijmr.IJMR_3_19.
       Full Text  Open Access Copy  Link to Item
    • John, William S., He Zhu, Paolo Mannelli, Geetha A. Subramaniam, Robert P. Schwartz, Jennifer McNeely, and Li-Tzy Wu. “Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco..” Drug Alcohol Depend 194 (January 1, 2019): 468–75. https://doi.org/10.1016/j.drugalcdep.2018.11.011.
       Full Text  Link to Item
    • Mannelli, Paolo, and Li-Tzy Wu. “Opioid use disorder deaths and the effects of medication therapy..” Am J Drug Alcohol Abuse 45, no. 3 (2019): 227–29. https://doi.org/10.1080/00952990.2019.1580289.
       Full Text  Link to Item
    • Mannelli, Paolo, Marvin Swartz, and Li-Tzy Wu. “Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone..” Am J Addict 27, no. 6 (September 2018): 471–76. https://doi.org/10.1111/ajad.12763.
       Full Text  Link to Item
    • Proeschold-Bell, Rae Jean, Donna M. Evon, Christina Makarushka, John B. Wong, Santanu K. Datta, Jia Yao, Ashwin A. Patkar, et al. “The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial..” Contemp Clin Trials 72 (September 2018): 73–85. https://doi.org/10.1016/j.cct.2018.07.003.
       Full Text  Link to Item
    • Bisaga, Adam, Paolo Mannelli, Miao Yu, Narinder Nangia, Christine E. Graham, D Andrew Tompkins, Thomas R. Kosten, Sarah C. Akerman, Bernard L. Silverman, and Maria A. Sullivan. “Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial..” Drug Alcohol Depend 187 (June 1, 2018): 171–78. https://doi.org/10.1016/j.drugalcdep.2018.02.023.
       Full Text  Link to Item
    • John, William S., He Zhu, Paolo Mannelli, Robert P. Schwartz, Geetha A. Subramaniam, and Li-Tzy Wu. “Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients..” Drug Alcohol Depend 187 (June 1, 2018): 79–87. https://doi.org/10.1016/j.drugalcdep.2018.01.035.
       Full Text  Link to Item
    • Wu, Li-Tzy, Udi E. Ghitza, He Zhu, Susan Spratt, Marvin Swartz, and Paolo Mannelli. “Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes..” Drug Alcohol Depend 186 (May 1, 2018): 86–93. https://doi.org/10.1016/j.drugalcdep.2018.01.008.
       Full Text  Link to Item
    • Bisaga, Adam, Paolo Mannelli, Maria A. Sullivan, Suzanne K. Vosburg, Peggy Compton, George E. Woody, and Thomas R. Kosten. “Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies..” Am J Addict 27, no. 3 (April 2018): 177–87. https://doi.org/10.1111/ajad.12711.
       Full Text  Link to Item
    • Wu, Li-Tzy, He Zhu, Paolo Mannelli, and Marvin S. Swartz. “Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States..” Drug Alcohol Depend 177 (August 1, 2017): 153–62. https://doi.org/10.1016/j.drugalcdep.2017.03.037.
       Full Text  Link to Item
    • Wu, Li-Tzy, Udi E. Ghitza, Anne L. Burns, and Paolo Mannelli. “The opioid overdose epidemic: opportunities for pharmacists..” Subst Abuse Rehabil 8 (2017): 53–55. https://doi.org/10.2147/SAR.S144268.
       Full Text  Open Access Copy  Link to Item
    • Mannelli, Paolo, and Li-Tzy Wu. “Family substance use screening: less to hide, more to gain..” Indian J Med Res 143, no. 6 (June 2016): 682–84. https://doi.org/10.4103/0971-5916.191920.
       Full Text  Open Access Copy  Link to Item
    • Mannelli, Paolo, and Li-Tzy Wu. “Primary care for opioid use disorder..” Subst Abuse Rehabil 7 (2016): 107–9. https://doi.org/10.2147/SAR.S69715.
       Full Text  Open Access Copy  Link to Item
    • Mannelli, Paolo, Li-Tzy Wu, Kathleen S. Peindl, Marvin S. Swartz, and George E. Woody. “Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial..” Drug Alcohol Depend 138 (May 1, 2014): 83–88. https://doi.org/10.1016/j.drugalcdep.2014.02.002.
       Full Text  Link to Item
    • Wu, Li-Tzy, Kathleen T. Brady, Paolo Mannelli, Therese K. Killeen, and Therese K. NIDA AAPI Workgroup. “Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study..” J Psychiatr Res 50 (March 2014): 26–35. https://doi.org/10.1016/j.jpsychires.2013.11.010.
       Full Text  Link to Item
    • Proeschold-Bell, R. J., S. Reif, B. Taylor, A. Patkar, P. Mannelli, J. Yao, and E. B. Quinlivan. “Substance Use Outcomes of an Integrated HIV-Substance Use Treatment Model Implemented by Social Workers and HIV Medical Providers.” Health and Social Work 41, no. 1 (February 24, 2014): e1–10. https://doi.org/10.1093/hsw/hlv088.
       Full Text
    • Wu, Li-Tzy, Dan G. Blazer, Kenneth R. Gersing, Bruce Burchett, Marvin S. Swartz, Paolo Mannelli, and Paolo NIDA AAPI Workgroup. “Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people..” J Psychiatr Res 47, no. 12 (December 2013): 1940–48. https://doi.org/10.1016/j.jpsychires.2013.08.022.
       Full Text  Link to Item
    • Mannelli, Paolo, Li-Tzy Wu, Kathleen S. Peindl, and David A. Gorelick. “Smoking and opioid detoxification: behavioral changes and response to treatment..” Nicotine Tob Res 15, no. 10 (October 2013): 1705–13. https://doi.org/10.1093/ntr/ntt046.
       Full Text  Link to Item
    • Mannelli, Paolo. “The burden of caring: drug users & their families..” Indian J Med Res 137, no. 4 (April 2013): 636–38.
       Link to Item
    • Wu, Li-Tzy, Marvin S. Swartz, Jeng-Jong Pan, Bruce Burchett, Paolo Mannelli, Chongming Yang, and Dan G. Blazer. “Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults..” Gen Hosp Psychiatry 35, no. 1 (January 2013): 74–82. https://doi.org/10.1016/j.genhosppsych.2012.06.014.
       Full Text  Link to Item
    • Wu, Li-Tzy, Marvin S. Swartz, Zunyou Wu, Paolo Mannelli, Chongming Yang, and Dan G. Blazer. “Alcohol and drug use disorders among adults in emergency department settings in the United States..” Ann Emerg Med 60, no. 2 (August 2012): 172-80.e5. https://doi.org/10.1016/j.annemergmed.2012.02.003.
       Full Text  Link to Item
    • Lee, Tong H., Steven T. Szabo, J Corey Fowler, Paolo Mannelli, O Barry Mangum, Wayne F. Beyer, Ashwin Patkar, and William C. Wetsel. “Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy..” Drug Alcohol Depend 124, no. 1–2 (July 1, 2012): 11–18. https://doi.org/10.1016/j.drugalcdep.2012.01.021.
       Full Text  Link to Item
    • Mannelli, Paolo, Kathleen Peindl, Li-Tzy Wu, Ashwin A. Patkar, and David A. Gorelick. “The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal..” Am J Drug Alcohol Abuse 38, no. 3 (May 2012): 200–205. https://doi.org/10.3109/00952990.2011.644003.
       Full Text  Link to Item
    • Proeschold-Bell, Rae Jean, Ashwin A. Patkar, Susanna Naggie, Lesleyjill Coward, Paolo Mannelli, Jia Yao, Patricia Bixby, and Andrew J. Muir. “An integrated alcohol abuse and medical treatment model for patients with hepatitis C..” Dig Dis Sci 57, no. 4 (April 2012): 1083–91. https://doi.org/10.1007/s10620-011-1976-4.
       Full Text  Open Access Copy  Link to Item
    • Mannelli, Paolo, Kathleen S. Peindl, Tong Lee, Kamal S. Bhatia, and Li-Tzy Wu. “Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives..” Curr Drug Abuse Rev 5, no. 1 (March 2012): 52–63.
       Link to Item
    • Mannelli, Paolo. “Once-monthly extended-release naltrexone injections improve opioid abstinence over 24 weeks compared with placebo..” Evidence Based Mental Health 14, no. 4 (November 2011). https://doi.org/10.1136/ebmh.2011.100153.
       Full Text
    • Mannelli, Paolo, Kathleen S. Peindl, and Li-Tzy Wu. “Pharmacological enhancement of naltrexone treatment for opioid dependence: a review..” Subst Abuse Rehabil 2011, no. 2 (June 2011): 113–23. https://doi.org/10.2147/SAR.S15853.
       Full Text  Open Access Copy  Link to Item
    • Mannelli, Paolo, Kathleen Peindl, Ashwin A. Patkar, Li-Tzy Wu, Haresh M. Tharwani, and David A. Gorelick. “Problem drinking and low-dose naltrexone-assisted opioid detoxification..” J Stud Alcohol Drugs 72, no. 3 (May 2011): 507–13. https://doi.org/10.15288/jsad.2011.72.507.
       Full Text  Link to Item
    • Wu, Li-Tzy, George E. Woody, Chongming Yang, Paolo Mannelli, and Dan G. Blazer. “Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions..” Subst Abuse Rehabil 2011, no. 2 (May 2011): 77–88. https://doi.org/10.2147/SAR.S18969.
       Full Text  Open Access Copy  Link to Item
    • Mannelli, Paolo, Kathi Peindl, Ashwin A. Patkar, Li-Tzy Wu, Chi-Un Pae, and David A. Gorelick. “Reduced cannabis use after low-dose naltrexone addition to opioid detoxification..” J Clin Psychopharmacol 30, no. 4 (August 2010): 476–78. https://doi.org/10.1097/JCP.0b013e3181e5c168.
       Full Text  Link to Item
    • Mannelli, P. “Agonist-antagonist combinations in opioid dependence: a translational approach..” Dipendenze Patologiche 5, no. 1 (January 2010): 17–24.
    • Mannelli, Paolo, Ashwin Patkar, Steve Rozen, Wayne Matson, Ranga Krishnan, and Rima Kaddurah-Daouk. “Opioid use affects antioxidant activity and purine metabolism: preliminary results..” Hum Psychopharmacol 24, no. 8 (December 2009): 666–75. https://doi.org/10.1002/hup.1068.
       Full Text  Link to Item
    • Patkar, Ashwin A., Steve Rozen, Paolo Mannelli, Wayne Matson, Chi-Un Pae, K Ranga Krishnan, and Rima Kaddurah-Daouk. “Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study..” Psychopharmacology (Berl) 206, no. 3 (October 2009): 479–89. https://doi.org/10.1007/s00213-009-1625-1.
       Full Text  Link to Item
    • Pae, Chi-Un, Prakash S. Masand, David M. Marks, Stan Krulewicz, Kathleen Peindl, Paolo Mannelli, and Ashwin A. Patkar. “History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia..” Prog Neuropsychopharmacol Biol Psychiatry 33, no. 6 (August 31, 2009): 996–1002. https://doi.org/10.1016/j.pnpbp.2009.05.005.
       Full Text  Link to Item
    • Wu, Li-Tzy, Andy C. Parrott, Christopher L. Ringwalt, Ashwin A. Patkar, Paolo Mannelli, and Dan G. Blazer. “The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention..” Addict Behav 34, no. 8 (August 2009): 654–61. https://doi.org/10.1016/j.addbeh.2009.03.029.
       Full Text  Link to Item
    • Mannelli, Paolo, Ashwin A. Patkar, Kathi Peindl, David A. Gorelick, Li-Tzy Wu, and Edward Gottheil. “Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial..” Addict Biol 14, no. 2 (April 2009): 204–13. https://doi.org/10.1111/j.1369-1600.2008.00119.x.
       Full Text  Link to Item
    • Mannelli, Paolo, Ashwin A. Patkar, Kathleen Peindl, Edward Gottheil, Li-Tzy Wu, and David A. Gorelick. “Early outcomes following low dose naltrexone enhancement of opioid detoxification..” Am J Addict 18, no. 2 (March 2009): 109–16. https://doi.org/10.1080/10550490902772785.
       Full Text  Link to Item
    • Pae, Chi-Un, David M. Marks, Prakash S. Masand, Kathleen Peindl, Christa Hooper-Wood, Changsu Han, Paolo Mannelli, Patrick Ciccone, and Ashwin A. Patkar. “Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial..” Clin Neuropharmacol 32, no. 2 (March 2009): 85–88. https://doi.org/10.1097/WNF.0b013e31817e559b.
       Full Text  Link to Item
    • Han, C., P. S. Masand, S. Krulewicz, K. Peindl, P. Mannelli, I. M. Varia, C. -. U. Pae, and A. A. Patkar. “Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release..” J Clin Pharm Ther 34, no. 1 (February 2009): 79–88. https://doi.org/10.1111/j.1365-2710.2008.00975.x.
       Full Text  Link to Item
    • Masand, Prakash S., Chi-Un Pae, Stan Krulewicz, Kathleen Peindl, Paolo Mannelli, Indu M. Varia, and Ashwin A. Patkar. “A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome..” Psychosomatics 50, no. 1 (January 2009): 78–86. https://doi.org/10.1176/appi.psy.50.1.78.
       Full Text  Link to Item
    • Pae, Chi-Un, Prakash S. Masand, David M. Marks, Stan Krulewicz, Changsu Han, Kathleen Peindl, Paolo Mannelli, and Ashwin A. Patkar. “History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release..” World J Biol Psychiatry 10, no. 4 Pt 2 (2009): 435–41. https://doi.org/10.1080/15622970902789155.
       Full Text  Link to Item
    • Patkar, Ashwin A., Paolo Mannelli, Kathleen Peindl, Kevin P. Hill, Li-Tzy Wu, Tong Lee, and Cynthia Kuhn. “Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence..” J Psychiatr Res 42, no. 14 (October 2008): 1213–19. https://doi.org/10.1016/j.jpsychires.2008.01.008.
       Full Text  Link to Item
    • Wu, Li-Tzy, Christopher L. Ringwalt, Paolo Mannelli, and Ashwin A. Patkar. “Hallucinogen use disorders among adult users of MDMA and other hallucinogens..” Am J Addict 17, no. 5 (September 2008): 354–63. https://doi.org/10.1080/10550490802269064.
       Full Text  Link to Item
    • Wu, Li-Tzy, Christopher L. Ringwalt, Paolo Mannelli, and Ashwin A. Patkar. “Prescription pain reliever abuse and dependence among adolescents: a nationally representative study..” J Am Acad Child Adolesc Psychiatry 47, no. 9 (September 2008): 1020–29. https://doi.org/10.1097/CHI.0b013e31817eed4d.
       Full Text  Link to Item
    • Pae, C. U., P. S. Masand, K. Peindl, C. Hooper-Wood, C. Han, P. Mannelli, P. Ciccone, and A. A. Patkar. “Reply to Dr Ng's comments on "A Randomized, Double-Blind, Placebo-Controlled Trial of Augmentation with An Extended Release Formulation of Methylphenidate in Outpatients with Treatment-Resistant Depression" [11].” Journal of Clinical Psychopharmacology 28, no. 1 (February 1, 2008): 117–18. https://doi.org/10.1097/jcp.0b013e3181629990.
       Full Text
    • Pae, Chi-Un, Prakash S. Masand, Kathleen Peindl, Paolo Mannelli, Changsu Han, David M. Marks, and Ashwin A. Patkar. “An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features..” Prim Care Companion J Clin Psychiatry 10, no. 3 (2008): 205–10. https://doi.org/10.4088/pcc.v10n0305.
       Full Text  Link to Item
    • Peindl, Kathleen S., Prakash Masand, Paolo Mannelli, Meera Narasimhan, and Ashwin Patkar. “Polypharmacy in pregnant women with major psychiatric illness: a pilot study..” J Psychiatr Pract 13, no. 6 (November 2007): 385–92. https://doi.org/10.1097/01.pra.0000300124.83945.b8.
       Full Text  Link to Item
    • Mannelli, Paolo, Ashwin A. Patkar, Kathleen Peindl, Heather W. Murray, Li-Tzy Wu, and Robert Hubbard. “Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence..” J Clin Psychopharmacol 27, no. 5 (October 2007): 468–74. https://doi.org/10.1097/jcp.0b013e31814e5e9d.
       Full Text  Link to Item
    • Mannelli, Paolo, Kathleen Peindl, Prakash S. Masand, and Ashwin A. Patkar. “Long-acting injectable naltrexone for the treatment of alcohol dependence..” Expert Review of Neurotherapeutics 7, no. 10 (October 2007): 1265–77. https://doi.org/10.1586/14737175.7.10.1265.
       Full Text
    • Peindl, Kathleen S., Paolo Mannelli, Li-Tzy Wu, and Ashwin A. Patkar. “Trends in nonheroin opioid abuse admissions: 1992-2004..” J Opioid Manag 3, no. 4 (July 2007): 215–23.
       Link to Item
    • Davidson, Colin, Rupa Gopalan, Cassandra Ahn, Qiang Chen, Paolo Mannelli, Ashwin A. Patkar, G Daniel Weese, Tong H. Lee, and Everett H. Ellinwood. “Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal..” Eur J Pharmacol 565, no. 1–3 (June 22, 2007): 113–18. https://doi.org/10.1016/j.ejphar.2007.02.056.
       Full Text  Link to Item
    • Mannelli, Paolo, and Chi Un Pae. “Medical comorbidity and alcohol dependence..” Current Psychiatry Reports 9, no. 3 (June 2007): 217–24. https://doi.org/10.1007/s11920-007-0022-x.
       Full Text
    • Tharwani, Haresh M., Pavan Yerramsetty, Paolo Mannelli, Ashwin Patkar, and Prakash Masand. “Recent advances in poststroke depression..” Curr Psychiatry Rep 9, no. 3 (June 2007): 225–31.
       Link to Item
    • Patkar, Ashwin A., Prakash S. Masand, Stan Krulewicz, Paolo Mannelli, Kathleen Peindl, Katherine L. Beebe, and Wei Jiang. “A randomized, controlled, trial of controlled release paroxetine in fibromyalgia..” Am J Med 120, no. 5 (May 2007): 448–54. https://doi.org/10.1016/j.amjmed.2006.06.006.
       Full Text  Link to Item
    • Patkar, Ashwin A., Prakash S. Masand, Chi-Un Pae, Kathleen Peindl, Christa Hooper-Wood, Paolo Mannelli, and Patrick Ciccone. “A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression..” J Clin Psychopharmacol 26, no. 6 (December 2006): 653–56. https://doi.org/10.1097/01.jcp.0000246212.03530.fd.
       Full Text  Link to Item
    • Mannelli, Paolo, Ashwin A. Patkar, Kathleen Peindl, Haresh Tharwani, Raman Gopalakrishnan, Kevin P. Hill, and Wade H. Berrettini. “Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls..” Psychiatry Res 144, no. 2–3 (November 15, 2006): 99–108. https://doi.org/10.1016/j.psychres.2006.01.012.
       Full Text  Link to Item
    • Patkar, Ashwin A., Paolo Mannelli, Kevin P. Hill, Kathleen Peindl, Chi-Un Pae, and Tong H. Lee. “Relationship of prolactin response to meta-chlorophenylpiperazine with severity of drug use in cocaine dependence..” Hum Psychopharmacol 21, no. 6 (August 2006): 367–75. https://doi.org/10.1002/hup.780.
       Full Text  Link to Item
    • Patkar, Ashwin A., Paolo Mannelli, Kathleen Peindl, Kevin P. Hill, Raman Gopalakrishnan, and Wade H. Berrettini. “Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients..” Psychopharmacology (Berl) 185, no. 1 (March 2006): 123–32. https://doi.org/10.1007/s00213-005-0261-7.
       Full Text  Link to Item
    • Van Bockstaele, E. J., C. Rudoy, P. Mannelli, V. Oropeza, and Y. Qian. “Elevated mu-opioid receptor expression in the nucleus of the solitary tract accompanies attenuated withdrawal signs after chronic low dose naltrexone in opiate-dependent rats..” Journal of Neuroscience Research 83, no. 3 (February 2006): 508–14. https://doi.org/10.1002/jnr.20738.
       Full Text
    • Mannelli, Paolo, Edward Gottheil, and Elisabeth J. Van Bockstaele. “Antagonist treatment of opioid withdrawal translational low dose approach..” J Addict Dis 25, no. 2 (2006): 1–8. https://doi.org/10.1300/J069v25n02_01.
       Full Text  Link to Item
    • Patkar, Ashwin A., Kathleen Peindl, Rajnish Mago, Paolo Mannelli, and Prakash S. Masand. “An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression..” Prim Care Companion J Clin Psychiatry 8, no. 2 (2006): 82–87. https://doi.org/10.4088/pcc.v08n0205.
       Full Text  Link to Item
    • Patkar, Ashwin A., Paolo Mannelli, Kathleen Peindl, Heather W. Murray, Bradley Meier, and Frank T. Leone. “Changes in tobacco smoking following treatment for cocaine dependence..” Am J Drug Alcohol Abuse 32, no. 2 (2006): 135–48. https://doi.org/10.1080/00952990500479209.
       Full Text  Link to Item
    • Ray, Riju, Glenn A. Doyle, James J. Crowley, Russell J. Buono, David W. Oslin, Ashwin A. Patkar, Paolo Mannelli, Peter A. DeMaria, Charles P. O’Brien, and Wade H. Berrettini. “A functional prodynorphin promoter polymorphism and opioid dependence..” Psychiatric Genetics 15, no. 4 (December 2005): 295–98. https://doi.org/10.1097/00041444-200512000-00013.
       Full Text
    • Mannelli, Paolo, Ashwin A. Patkar, Heather W. Murray, Kenneth Certa, Kathleen Peindl, Marja Mattila-Evenden, and Wade H. Berrettini. “Polymorphism in the serotonin transporter gene and response to treatment in African American cocaine and alcohol-abusing individuals..” Addict Biol 10, no. 3 (September 2005): 261–68. https://doi.org/10.1080/13556210500235540.
       Full Text  Link to Item
    • Smith, Rachel J., Glenn A. Doyle, Angela M. Han, James J. Crowley, David W. Oslin, Ashwin A. Patkar, Paolo Mannelli, Peter A. Demaria, Charles P. O’brien, and Wade H. Berrettini. “Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence..” Am J Med Genet B Neuropsychiatr Genet 133B, no. 1 (February 5, 2005): 105–9. https://doi.org/10.1002/ajmg.b.30105.
       Full Text  Link to Item
    • Patkar, Ashwin A., Vikas Batra, Paolo Mannelli, Sarah Evers-Casey, Michael J. Vergare, and Frank T. Leone. “Medical symptoms associated with tobacco smoking with and without marijuana abuse among crack cocaine-dependent patients..” The American Journal on Addictions 14, no. 1 (January 2005): 43–53. https://doi.org/10.1080/10550490590899844.
       Full Text
    • McCarthy, Lois E., Paolo Mannelli, Michelle Niculescu, Kevin Gingrich, Ellen M. Unterwald, and Michelle E. Ehrlich. “The distribution of cocaine in mice differs by age and strain..” Neurotoxicology and Teratology 26, no. 6 (November 2004): 839–48. https://doi.org/10.1016/j.ntt.2004.07.004.
       Full Text
    • Patkar, Ashwin A., Paolo Mannelli, Kenneth M. Certa, Kathleen Peindl, Heather Murray, Michael J. Vergare, and Wade H. Berrettini. “Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence..” Psychopharmacology (Berl) 176, no. 1 (October 2004): 74–81. https://doi.org/10.1007/s00213-004-1856-0.
       Full Text  Link to Item
    • Mannelli, Paolo, Edward Gottheil, James F. Peoples, Veronica C. Oropeza, and Elisabeth J. Van Bockstaele. “Chronic very low dose naltrexone administration attenuates opioid withdrawal expression..” Biol Psychiatry 56, no. 4 (August 15, 2004): 261–68. https://doi.org/10.1016/j.biopsych.2004.05.013.
       Full Text  Link to Item
    • Patkar, Ashwin A., Wade H. Berrettini, Paolo Mannelli, Raman Gopalakrishnan, Margret R. Hoehe, Louai Bilal, Stephen Weinstein, and Michael J. Vergare. “Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers..” Psychiatr Genet 14, no. 1 (March 2004): 25–32.
       Link to Item
    • Patkar, Ashwin A., Charles C. Thornton, Paolo Mannelli, Kevin P. Hill, Edward Gottheil, Michael J. Vergare, and Stephen P. Weinstein. “Comparison of pretreatment characteristics and treatment outcomes for alcohol-, cocaine-, and multisubstance-dependent patients..” J Addict Dis 23, no. 1 (2004): 93–109. https://doi.org/10.1300/J069v23n01_08.
       Full Text  Link to Item
    • Patkar, Ashwin A., Heather W. Murray, Paolo Mannelli, Edward Gottheil, Stephen P. Weinstein, and Michael J. Vergare. “Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African-American cocaine-dependent patients..” J Addict Dis 23, no. 2 (2004): 109–22. https://doi.org/10.1300/J069v23n02_08.
       Full Text  Link to Item
    • Murray, H. W., A. A. Patkar, P. Mannelli, P. DeMaria, A. M. Desai, and M. J. Vergare. “Relationship of Aggression, Sensation Seeking, and Impulsivity, with Severity of Cocaine Use.” Addictive Disorders and Their Treatment 2, no. 4 (December 16, 2003): 113–21. https://doi.org/10.1097/00132576-200302040-00002.
       Full Text
    • Thornton, Charles C., Ashwin A. Patkar, Heather W. Murray, Paolo Mannelli, Edward Gottheil, Michael J. Vergare, and Stephen P. Weinstein. “High- and low-structure treatments for substance dependence: role of learned helplessness..” Am J Drug Alcohol Abuse 29, no. 3 (August 2003): 567–84. https://doi.org/10.1081/ada-120023459.
       Full Text  Link to Item
    • Mannelli, Paolo, Edward Gottheil, Antonio Buonanno, and Sergio De Risio. “Use of very low-dose naltrexone during opiate detoxification..” Journal of Addictive Diseases 22, no. 2 (January 2003): 63–70. https://doi.org/10.1300/j069v22n02_05.
       Full Text
    • Pozzi, G., C. Del Borgo, A. Del Forno, A. Genualdo, P. Mannelli, and M. Fantoni. “Psychological discomfort and mental illness in patients with AIDS: implications for home care..” Aids Patient Care and Stds 13, no. 9 (September 1999): 555–64. https://doi.org/10.1089/apc.1999.13.555.
       Full Text
    • De Giacomo, M., R. Gaspari, A. Stefanelli, A. Barelli, and P. Mannelli. “Emergency therapeutical approach simulating ultrarapid opioid detoxification in methadone withdrawal precipitated by erroneous administration of naltrexone..” European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine 6, no. 2 (June 1999): 153–55.
    • Mannelli, P., S. De Risio, G. Pozzi, L. Janiri, and M. De Giacomo. “Serendipitous rapid detoxification from opiates: the importance of time-dependent processes..” Addiction 94, no. 4 (April 1999): 589–91. https://doi.org/10.1046/j.1360-0443.1999.94458913.x.
       Full Text  Link to Item
    • Janiri, L., A. Hadjichristos, A. Buonanno, R. Rago, P. Mannelli, and S. de Risio. “Adjuvant trazodone in the treatment of alcoholism: an open study..” Alcohol and Alcoholism (Oxford, Oxfordshire) 33, no. 4 (July 1998): 362–65. https://doi.org/10.1093/oxfordjournals.alcalc.a008405.
       Full Text
    • Janiri, L., G. Gobbi, P. Mannelli, G. Pozzi, A. Serretti, and E. Tempesta. “Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics..” Int Clin Psychopharmacol 11, no. 2 (June 1996): 109–17.
       Link to Item
    • Janiri, L., P. Mannelli, A. M. Persico, A. Serretti, and E. Tempesta. “Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine..” Drug Alcohol Depend 36, no. 2 (October 1994): 139–45. https://doi.org/10.1016/0376-8716(94)90096-5.
       Full Text  Link to Item
    • Janiri, L., P. Mannelli, A. Serretti, and E. Tempesta. “Low-dose buprenorphine detoxification in long term methadone addicts.” Regulatory Peptides 53, no. SUPPL. 1 (February 21, 1994). https://doi.org/10.1016/0167-0115(94)90351-4.
       Full Text
    • Mannelli, P., L. Janiri, M. C. Mizzoni, and E. Tempesta. “Sources of differentiation of cocaine withdrawal symptomatology.” European Neuropsychopharmacology 4, no. 3 (January 1, 1994). https://doi.org/10.1016/0924-977X(94)90232-1.
       Full Text
    • Mannelli, P., L. Janiri, E. Tempesta, and R. T. Jones. “Prediction in drug abuse: cocaine interactions with alcohol and buprenorphine..” Br J Psychiatry Suppl, no. 21 (September 1993): 39–45.
       Link to Item
    • Bartoloni, C., L. Guidi, A. L. di Giovanni, L. Antico, F. Cursi, R. Pili, A. Tricerri, et al. “Psychological status, life and social conditions: A study in a population of institutionalized elderly people.” International Journal of Geriatric Psychiatry 8, no. 5 (January 1, 1993): 419–26. https://doi.org/10.1002/gps.930080509.
       Full Text
    • Mannelli, P., L. Janiri, E. Tempesta, and R. T. Jones. “Prediction in drug abuse: Cocaine interactions with alcohol and buprenorphine.” British Journal of Psychiatry 163, no. SEPT. SUPPL. 21 (January 1, 1993): 39–45.
    • Mannelli, P., S. Mazza, L. Janiri, and E. Tempesta. “Serotoninergic hypothesis on the drug mechanism of cocaine.” Bollettino Di Psichiatria Biologica 7, no. 3 (December 1, 1991): 56–59.
    • Janiri, L., A. Di Giovanni, A. Persico, E. Zeppetelli, P. Mannelli, L. Antico, and E. Tempesta. “Benzodiazepine use and dependency risk in geriatric inpatients.” Minerva Psichiatrica 32, no. 3 (October 28, 1991): 151–63.
    • Janiri, L., A. Di Giovanni, A. Persico, E. Zeppetelli, P. Mannelli, L. Antico, and E. Tempesta. “[Benzodiazepines consumption and risk of dependence in institutionalized geriatric patients]..” Minerva Psichiatr 32, no. 3 (July 1991): 151–63.
       Link to Item
    • Janiri, L., P. Mannelli, A. M. Persico, S. Diodato, and E. Tempesta. “Zipeprol is a newly abused antitussive with an opioid spectrum and hallucinogenic effects..” Drug Alcohol Depend 27, no. 2 (March 1991): 121–25. https://doi.org/10.1016/0376-8716(91)90030-3.
       Full Text  Link to Item
    • Janiri, L., A. D. Giovanni, A. Persico, E. Zeppetelli, P. Mannelli, L. Antico, and E. Tempesta. “Benzodiazepine use and dependency risk in geriatric inpatients.” Minerva Psichiatrica 32, no. 3 (1991): 151–63.
    • Mannelli, P., S. Mazza, L. Janiri, and E. Tempesta. “Serotoninergic hypothesis on the drug mechanism of cocaine.” Bollettino Di Psichiatria Biologica 7, no. 3 (1991): 56–59.
    • Tempesta, E., L. Janiri, and P. Mannelli. “Patterns of cocaine abuse and indications for treatment.” European Neuropsychopharmacology 1, no. 3 (January 1, 1991): 259–61. https://doi.org/10.1016/0924-977X(91)90515-V.
       Full Text
    • Tempesta, E., L. Janiri, P. Mannelli, A. M. Persico, and S. Diodato. “Clinical reports on recent abuse of an antitussive..” Br J Addict 85, no. 6 (June 1990): 815–16. https://doi.org/10.1111/j.1360-0443.1990.tb01695.x.
       Full Text  Link to Item
    • Mannelli, P., L. Janiri, M. De Marinis, and E. Tempesta. “Lefetamine: new abuse of an old drug--clinical evaluation of opioid activity..” Drug Alcohol Depend 24, no. 2 (October 1989): 95–101. https://doi.org/10.1016/0376-8716(89)90071-9.
       Full Text  Link to Item
    • Janiri, L., P. Mannelli, C. Pirrongelli, M. Lo Monaco, and E. Tempesta. “Lephetamine abuse and dependence: clinical effects and withdrawal syndrome..” Br J Addict 84, no. 1 (January 1989): 89–95. https://doi.org/10.1111/j.1360-0443.1989.tb00555.x.
       Full Text  Link to Item

  • Book Sections

    • Mannelli, P., L. T. Wu, and K. T. Brady. “Pharmacological and Integrated Treatments in Older Adults with Substance Use Disorders.” In Substance Use and Older People, 9781119975380:273–94, 2014. https://doi.org/10.1002/9781118430965.ch20.
       Full Text

  • Conference Papers

    • Mannelli, Paolo, D Andrew Tompkins, Sarah Akerman, Miao Yu, Narinder Nangia, Christine Graham, Maria Sullivan, Thomas Kosten, and Adam Bisaga. “Transition to Extended-release Naltrexone: Heroin Versus Prescription Opioid Users.” In American Journal on Addictions, 27:323–24. WILEY, 2018.
       Link to Item
    • Sullivan, Maria, Paolo Mannelli, Miao Yu, Narinder Nangia, Christine Graham, Irena Webster, D Andrew Tompkins, Thomas Kosten, Sarah Akerman, and Bernard Silverman. “Outpatient Transition to Extended-release Naltrexone in Patients With Opioid-use Disorder.” In American Journal on Addictions, 27:323–323. WILEY, 2018.
       Link to Item
    • Patkar, Ashwin A., Prakash S. Masand, Stan Krulewicz, Paolo Mannelli, Kathleen Peindl, Katherine L. Beebe, and Wei Jiang. “A randomized, controlled, trial of controlled release paroxetine in fibromyalgia.” In American Journal of Medicine, 120:448–54. ELSEVIER SCIENCE INC, 2007. https://doi.org/10.1016/j.amjmed.2006.06.006.
       Full Text  Link to Item
    • Gopalan, Rupa, Cassie Ahn, Paolo Mannelli, Ashwin Patkar, Dan Weese, Tong Lee, Everett Ellinwood, and Colin Davidson. “Bupropion reinstates cocaine seeking behavior in rats.” In Neuropsychopharmacology, 31:S200–S200. NATURE PUBLISHING GROUP, 2006.
       Link to Item
    • Mannelli, Paolo, Ashwin Patkar, Cynthia Kuhn, and Philip Perera. “Sodium oxybate for the treatment of fibromyalgia: A double-blind, placebo-controlled trial.” In Neuropsychopharmacology, 31:S260–S260. NATURE PUBLISHING GROUP, 2006.
       Link to Item
    • Masand, P. S., C. -. U. Pae, K. Peindl, C. Hooper-Wood, P. E. Ciccone, P. Mannelli, and A. A. Patkar. “A randomized, double-blind, placebo-controlled, flexible-dose, trial of augmentation with OROS methylphenidate in Treatment Resistant Depression.” In International Journal of Neuropsychopharmacology, 9:S235–S235. CAMBRIDGE UNIV PRESS, 2006.
       Link to Item
    • Mannelli, P., E. Gottheil, C. Thornton, S. Weinstein, and M. Levine. “Continuing care versus revolving door following opiate detoxification.” In Journal of Addictive Diseases, 22:123–123. HAWORTH PRESS INC, 2003.
       Link to Item
    • Mannelli, P., and E. Gottheil. “Very low antagonist dosing in opiate detoxification.” In Journal of Addictive Diseases, 20:157–157. HAWORTH PRESS INC, 2001.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.